CIK 0001709941 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
BioAge Labs, Inc.
Sign in to watch- Ticker
- BIOA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474721157
- Phone
- 510-806-1445
- Business address
- 5885 HOLLIS STREET, SUITE 370, EMERYVILLE, CA, 94608
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-10 | Davidson Michael H. Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2026-06-10 | ENRIGHT PATRICK G Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2026-06-10 | HEALY JAMES Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2026-06-10 | GARNIER JEAN PIERRE Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2026-04-23 | GOLDSTEIN DOV A MD Chief Financial Officer | Option exercise | +3,542 | $4.38 | $16K | 36,575 |
| 2026-04-23 | GOLDSTEIN DOV A MD Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −3,542 | 155,833 | ||
| 2026-04-01 | RUBIN PAUL D Chief Medical Officer | Option exercise 10b5-1 | +5,437 | $4.11 | $22K | 5,437 |
| 2026-04-01 | RUBIN PAUL D Chief Medical Officer | Option exercise 10b5-1 | +3,383 | $6.57 | $22K | 8,820 |
| 2026-04-01 | RUBIN PAUL D Chief Medical Officer | Sale 10b5-1 | −8,820 | $17.81 | $157K | 0 |
| 2026-04-01 | RUBIN PAUL D Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,437 | 0 | ||
| 2026-04-01 | RUBIN PAUL D Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,383 | 0 | ||
| 2026-03-02 | RUBIN PAUL D Chief Medical Officer | Option exercise 10b5-1 | +5,433 | $4.11 | $22K | 5,433 |
| 2026-03-02 | RUBIN PAUL D Chief Medical Officer | Option exercise 10b5-1 | +2,000 | $6.57 | $13K | 7,433 |
| 2026-03-02 | RUBIN PAUL D Chief Medical Officer | Sale 10b5-1 | −7,433 | $20.30 | $151K | 0 |
| 2026-03-02 | RUBIN PAUL D Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,433 | 5,437 | ||
| 2026-03-02 | RUBIN PAUL D Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,000 | 3,383 | ||
| 2026-03-01 | GOLDSTEIN DOV A MD Chief Financial Officer | Option exercise | +3,542 | $4.38 | $16K | 33,033 |
| 2026-03-01 | GOLDSTEIN DOV A MD Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −3,542 | 159,375 | ||
| 2026-02-17 | Morgen Eric Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +110,000 | 110,000 | ||
| 2026-02-17 | Morgen Eric Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +12,500 | 12,500 |
Page 2 of 7 · 124 trades